Semaglutide pill for liver fat in transplant patients with diabetes
Part of Hormones & metabolism clinical trials.
This study tests if an oral semaglutide pill can reduce liver fat and improve body composition in people who have had a liver transplant and have diabetes. It may help manage weight and blood sugar after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years or older
- Your liver transplant was at least 3 months ago
- You have diabetes and take metformin and/or insulin, with HbA1c (average blood sugar) of 9% or less
- Your body mass index (BMI) is above 25 (overweight or obese)
- You are medically stable and agree to follow study rules
- You are willing to have an MRI (magnetic resonance imaging) scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two diabetes medicines—semaglutide and sitagliptin—in people who have had a liver transplant and have type 2 diabetes (or diabetes after transplant). It’s looking to see which medicine works better and is safe for blood sugar control in the transplant setting.
This study looks at whether the oral medication semaglutide can help treat chronic kidney disease in people who have both type 2 diabetes and a fatty liver related to metabolism. It aims to see if the drug can improve kidney function and liver health.
This trial tests semaglutide (a diabetes/weight-loss medicine) to help prevent weight gain after liver transplant. It is also looking at blood sugar and safety while you continue your transplant medicines.
This trial tests semaglutide, a medicine that helps lower blood sugar, in people who develop high blood sugar shortly after a kidney transplant. It may help control blood sugar without harming the transplanted kidney, while also checking safety in this specific group.
This trial tests if the drug semaglutide can prevent the development of diabetes in people who have recently had a kidney transplant. It may help those at higher risk for post-transplant diabetes.
This study tests if a daily semaglutide pill can reduce harmful fat around the heart in people with type 2 diabetes who had a heart attack 2 to 9 months ago. It aims to see if this treatment can improve heart health.
Hear when a new Liver Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.